CODX
HEALTHCARECo-Diagnostics Inc
$1.64+0.05 (+3.14%)LIVE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving CODX Today?
No stock-specific AI insight has been generated for CODX yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.35$46.50
$1.64
Fundamentals
Market Cap$6M
P/E Ratio—
EPS$-35.25
Dividend Yield—
Dividend / Share—
ROE-1.3%
Profit Margin—
Debt / Equity—
Trading
Volume58K
Avg Volume (10D)—
Shares Outstanding3.6M
CODX News
20 articles- Co-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for Manufacturing Facility in Saudi Arabia's Sudair Industrial CityYahoo Finance·May 8, 2026
- GoodRx Holdings, Inc. (GDRX) Q1 Earnings Match EstimatesYahoo Finance·May 6, 2026
- Co-Diagnostics Announces First Quarter 2026 Earnings Release Date and WebcastYahoo Finance·Apr 30, 2026
- Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C.Yahoo Finance·Apr 16, 2026
- Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, GermanyYahoo Finance·Apr 14, 2026
- Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC UtahYahoo Finance·Apr 9, 2026
- Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial CityYahoo Finance·Apr 2, 2026
- Co-Diagnostics, Inc. Q4 2025 Earnings Call SummaryMoby·Apr 1, 2026
- Co-Diagnostics Inc (CODX) Q4 2025 Earnings Call Highlights: Strategic Expansions and Financial ...Yahoo Finance·Apr 1, 2026
- Co-Diagnostics Reports Full Year 2025 Financial ResultsBenzinga·Mar 31, 2026
- Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health OrganizationBenzinga·Mar 25, 2026
- Co-Diagnostics (CODX) Expands CoSara Distribution Territory Across South AsiaYahoo Finance·Mar 20, 2026
- Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South AsiaYahoo Finance·Mar 20, 2026
- Sera Prognostics, Inc. (SERA) Reports Q4 Loss, Lags Revenue EstimatesYahoo Finance·Mar 18, 2026
- Co-Diagnostics Announces Fourth Quarter and Full Year 2025 Earnings Release Date and WebcastYahoo Finance·Mar 17, 2026
- Co-Diagnostics to Present at Medical Korea 2026Yahoo Finance·Mar 16, 2026
- Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform TechnologiesYahoo Finance·Mar 12, 2026
- Auna S.A. (AUNA) Tops Q4 Earnings and Revenue EstimatesYahoo Finance·Mar 10, 2026
- Co-Diagnostics Regains Compliance with Nasdaq Listing RequirementsYahoo Finance·Mar 10, 2026
- Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs DubaiYahoo Finance·Feb 9, 2026
All 20 articles loaded
Price Data
Open$1.59
Previous Close$1.59
Day High$1.64
Day Low$1.54
52 Week High$46.50
52 Week Low$1.35
52-Week Range
$1.35$46.50
$1.64
Fundamentals
Market Cap$6M
P/E Ratio—
EPS$-35.25
Dividend Yield—
Dividend / Share—
ROE-1.3%
Profit Margin—
Debt / Equity—
Trading
Volume58K
Avg Volume (10D)—
Shares Outstanding3.6M
About Co-Diagnostics Inc
Co-Diagnostics, Inc., a molecular diagnostic company, develops, manufactures, and sells reagents used for diagnostic tests that function by detecting and / or analyzing nucleic acid molecules. The company is headquartered in Salt Lake City, Utah.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—